Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Article in Chinese | MEDLINE | ID: mdl-30808133

ABSTRACT

Objective: To understand the auditory cortex resting-state fMRI features for adult post-lingual deafness.Method: The author performed functional connectivity analysis on the study subjects with resting-state fMRI,the region of interest(ROI) of which were based separately on the left and right sides of primary auditory cortex. The data were collected from 8 cases with severe or above sensorineurally post-lingual deafness,compared to a control group of 8 cases with normal hearing. Result: When ROI were based on the left A1 areas of all subjects, the main activating area in the control group was bilateral superior temporal gyrus(STG), while the post-lingual deafness group included the bilateral STG, pre-central gyri, left Transverse temporal gyrus(TTG), post-central gyri and right TTG (P<0.01); when ROI were based on the right A1 areas of all subjects, the main activating area in the control group was the bilateral STG, while the post-lingual deafness group included the bilateral STG, right precentral gyri and post-central gyr i(P<0.01). The data showed statistical significance(P<0.05). Conclusion: After hearing loss functional reorganization takes place in the brains of adults with post-lingual deafness, resulting in possible enhancement of visual sense, tactile sense and other sensory systems in order to compensate information acquisition in daily life. .


Subject(s)
Auditory Cortex , Deafness , Magnetic Resonance Imaging , Adult , Auditory Cortex/diagnostic imaging , Auditory Cortex/physiopathology , Deafness/diagnostic imaging , Deafness/physiopathology , Humans , Tongue
2.
Article in Chinese | MEDLINE | ID: mdl-30293259

ABSTRACT

Objective: To explore the therapeutic effects of dendritic cells (DC) modified by the dust-mite-allergen(Der p1) gene on mouse model of allergic rhinitis (AR). Methods: DC modified by the Der p1 gene (Der p1-DC) were prepared.Using random number table, 24 Balb\c mice were divided into four groups: immature DC (imDC)/AR group, dexamethasone/AR group, Der p1-DC/AR group and control group, with 6 mice in each group.AR mouse model was built with Der p1 and the mouse model of AR was established.The AR mice were respectively given by abdominal injection of Der p1-DC, imDC and dexamethasone.Normal control mice were treated with physiologic saline.ELISA method was used for determining the content of IgE, IgG1and histamine in blood.The relative expression of mRNA of IL-4 and IL-13 on nasal mucosa with protein was analyzed by RT-PCR and Westen blot methods.All the data were statistically analyzed by SPSS 19.0 statistical software, and the variance analysis was used in multiple groups of average samples. Results: The contents of IgE, IgG1 and histamine in the mice of Der p1-DC/AR group were lower than those in imDC/AR group ((0.560±0.110) OD 450 nm vs (1.150±0.280) OD 450 nm, (0.690±0.054) OD 450 nm vs (0.920±0.125) OD 450 nm, (4 145±670) pg/ml vs (7 685±669) pg/ml, t value was 4.80, 4.14, 9.16, respectively, all P<0.05), and the expression of IL-4 and IL-13 on nasal mucosa in Der p1-DC/AR group was remarkedly lower than those in imDC/AR group (0.41±0.25 vs 1.59±1.02, 0.26±0.01 vs 1.10±0.09, t value was 2.75, 22.72, respectively, all P<0.05). There was no statistically significant difference between the mice treated with Der p1-DC and dexamethasone group. Conclusions: The results showed that Der p1-DC could reduce inflammation in AR mice and decrease the expression of IL-4 and IL-13. It suggested that Der p1-DC can be used in the immunotherapy of AR mouse.


Subject(s)
Antigens, Dermatophagoides/genetics , Arthropod Proteins/genetics , Cysteine Endopeptidases/genetics , Dendritic Cells/immunology , Dust , Immunotherapy/methods , Mites/immunology , Rhinitis, Allergic/therapy , Animals , Antigens, Dermatophagoides/immunology , Arthropod Proteins/immunology , Cysteine Endopeptidases/immunology , Dexamethasone/therapeutic use , Disease Models, Animal , Glucocorticoids/therapeutic use , Histamine/blood , Immunoglobulin E/blood , Immunoglobulin G/blood , Interleukin-13/genetics , Interleukin-4/genetics , Mice , Mice, Inbred BALB C , Nasal Mucosa/immunology , RNA, Messenger/blood , Rhinitis, Allergic/blood
3.
Article in Chinese | MEDLINE | ID: mdl-29921048

ABSTRACT

Objective:To investigate the diagnosis and treatment of canal conversion during canalith repositioning procedure for benign paroxysmal positional vertigo.Method:The clinic features, nystagmus characteristics, diagnosis and treatment of the patients with benign paroxysmal positional vertigo who suffered from canal conversion during canalith repositioning procedure were analyzed retrospectively.All patients'positioning test and canalith repositioning procedure were done with the aid of videonystagmography.Result:A total of 186 patients with benign paroxysmal positional vertigo were diagnosed and performed canalith repositioning procedure.Eight patients (4.3%) developed canal conversion after canalith repositioning procedure.Of these 8 patients,5 cases with posterior canal canalolithiasis converted to lateral canal canalolithiasis,2 cases with lateral canal canalolithiasis converted to posterior canal canalolithiasis,and 1 case with posterior canal canalolithiasis converted to anterior canal canalolithiasis. All cases recovered well under the corresponding repositioning procedure.Conclusion:The change of the characteristics of positioning nystagmus is the major diagnostic feature of canal conversion. Accurate diagnosis and targeted repositioning procedure are the key to the success of canal conversion treatment.


Subject(s)
Benign Paroxysmal Positional Vertigo/therapy , Nystagmus, Pathologic , Patient Positioning , Humans , Posture , Retrospective Studies , Semicircular Canals
4.
Article in Chinese | MEDLINE | ID: mdl-28728239

ABSTRACT

Objective: To explore the effect of hydrogen-rich saline on the CD4(+) CD25(+) Foxp3(+) Treg cells in a guinea pig model of allergic rhinitis (AR) and investigate the underling anti-inflammatory mechanism. Methods: Using random number table, eighteen guinea pigs were divided into three groups (control group/AR group/HRS group, n=6 of each group). AR guinea pig model was built with ovalbumin and aluminum. The guinea pigs were injected with hydrogen-rich saline (HRS group) for ten days after sensitation. And control group was injected with equal normal saline at the same time. Number of sneezes, degree of runny nose and nasal rubbing movements were scored. Peripheral blood eosinophil count was recorded. The content of interleukin 10(IL-10) and transforming growth factor ß (TGF-ß) in the serum were detected by enzyme-linked immunosorbent assay (ELISA). Immunohistochemical method was taken to detect IL-10 and TGF-ß in nasal mucosa. The proportion of CD4(+) CD25(+) Foxp3(+) T cells in the CD4(+) T cells of spleen and peripheral blood were determined with flow cytometry. SPSS 17.0 software was used to analyze the data. Results: There was significant difference in symptom scores among them. The scores of AR group preceded control group, and HRS could decrease the scores of AR ((6.29±1.79) vs (1.01±0.71), (4.50±0.84) vs (6.29±1.79), F=24.725, all P<0.05). The highest number of eosinophils in the peripheral blood belonged to control group, and the number of eosinophils were dramatically reduced after HRS administration ((0.41±0.05)×10(9)/L vs (0.25±0.03 )×10(9)/L, (0.32±0.03)×10(9)/L vs (0.41±0.05)×10(9)/L, F=70.05, all P<0.05). The content of IL-10 and TGF-ß in control group is peak ((86.88±17.17) pg/ml, (598.28±72.70) pg/ml, respectively), and compared with AR group, HRS also increased the expression of IL-10 and TGF-ß of peripheral blood ((72.54±11.75) pg/ml vs (53.49±10.07) pg/ml, (530.23±57.15) pg/ml vs (482.69±65.96) pg/ml, F value was 28.357, 14.128, respectively, all P<0.05). The proportion of CD4(+) CD25(+) Foxp3(+) Treg cells in controls exceeded HRS group and AR group (1.81%±0.10%, 1.29%±0.74%, respectively), and HRS treatment increased the ratio of CD4(+) CD25(+) Foxp3(+) Treg cells than AR group of peripheral blood ((1.50%±0.11%) vs (1.15%±0.11%), F=168.96, P<0.05). But there was no significant diferences in splene tissue ((1.01%±0.08%) vs (0.98%±0.09%), F=97.381, P>0.05). Conclusion: Both the number and the cytokine secretion of CD4(+) CD25(+) Foxp3(+) Treg cells are decreased in AR group, HRS may inhibit inflammatory response and ameliorate AR via improving the number and the cytokine secretion.


Subject(s)
Hydrogen , Rhinitis, Allergic/immunology , Sodium Chloride/pharmacology , T-Lymphocytes, Regulatory/drug effects , Animals , CD4-Positive T-Lymphocytes/chemistry , CD4-Positive T-Lymphocytes/drug effects , Disease Models, Animal , Eosinophils , Flow Cytometry , Forkhead Transcription Factors/analysis , Guinea Pigs , Interleukin-10/analysis , Nasal Mucosa/chemistry , Ovalbumin , Random Allocation , Sodium Chloride/chemistry , T-Lymphocytes, Regulatory/chemistry , Transforming Growth Factor beta/analysis
6.
Article in Chinese | MEDLINE | ID: mdl-29871281

ABSTRACT

Objective:To investigate the efficacy and safety of treating laryngeal hemangioma by injecting bleomycin with self-made laryngeal microinjector under the suspension laryngoscope and operating microscope.Method:Thirteen patients with hemangioma of larynx(diameters of tumors range from 1.2-3.8 cm) were admitted and treated by injecting bleomycin with a modified laryngeal micro-injector under the suspension laryngoscope and operating microscope from January 2012 to September 2016. According to the tumor size, 4.5-7.5 mg bleomycin was injected and the patients received treatment every four weeks until there were no evident tumor residues. Result:Four of the 13 patients were cured after the first injection, 6 were cured after the second injection, and 3 cured after the third injection. All cases were followed up without recurrence. Conclusion:Bleomycin injection with a modified laryngeal micro injector under the suspension laryngoscope and operating microscope is proved to be a effective measure with the advantage of precise, minimal- invasive, and efficient therapeutic effect in treatment of laryngeal hemangioma.


Subject(s)
Antibiotics, Antineoplastic/administration & dosage , Bleomycin/administration & dosage , Hemangioma/drug therapy , Laryngeal Neoplasms/drug therapy , Laryngoscopy , Humans , Laryngoscopes , Larynx , Neoplasm Recurrence, Local
7.
Article in Chinese | MEDLINE | ID: mdl-29798159

ABSTRACT

Objective:To study the variation of the electrode impedance in different periods after cochlear implantation performed with round window insertion in steroid deposition, and to provide the basis for the postoperative debugging of the speech processor. Method:Detected the electrode impedance of 47 cochlear receivers after operation in steroid deposition from September 2014 to October 2015, compared the impedance values between different periods, and different groups according to their locations. Result:The average impedance of all the electrodes and the 3 subgroups are low after implantation (period A0), peaked at the first month (period A1), then decreased slowly, and then turned to be stable at the sixth month (period A3); the impedance values were no significantly different between the sixth month (period A3) and the twelfth month (period A4) while were significantly different between each of other two periods (P<0.05); the apical group had the highest impedance and the basal group had the lowest impedance in all the 5 periods. Conclusion:The local use of steroid can decrease the impedance of the electrode after implantation. The impedance value were the low during operation, peaked at the first month, then decreased slowly, and turned to be stable at the sixth month. As a result, the cochlear implant should be debugged at regular intervals in 6 months after operation to obtain the best hearing status.


Subject(s)
Cochlear Implantation , Electric Impedance , Round Window, Ear/physiology , Steroids/administration & dosage , Cochlea , Cochlear Implants , Hearing Loss , Humans
8.
Article in Chinese | MEDLINE | ID: mdl-29798280

ABSTRACT

My department reports a case of giant rhinolith.Rhinolith is a rare and slow-progressing disease. Clinically, rhinolith is easily to be misdiagnosed as sinusitis or sinus tumor. High-resolution computed tomography (HRCT) can be used to diagnose of rhinolith and differentiate it from sinusitis or sinus tumors. HRCT can also provide reliable evidence for evaluating surgery difficulty level and determining operation method.


Subject(s)
Calculi/diagnostic imaging , Calculi/surgery , Nasal Cavity/diagnostic imaging , Nasal Cavity/surgery , Paranasal Sinus Diseases/diagnostic imaging , Paranasal Sinus Diseases/surgery , Diagnosis, Differential , Humans , Nose Neoplasms , Sinusitis , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...